Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Viracta Therapeutics, Inc. (VIRX) had Operating Cash Flow per Share of $-0.63 for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-10.55M |
|
-- |
|
-- |
|
$10.19M |
|
$-10.19M |
|
$-0.37M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-10.55M |
|
$-10.19M |
|
$-10.20M |
|
39.57M |
|
39.57M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$21.80M |
|
$0.11M |
|
$0.15M |
|
$21.96M |
|
$28.57M |
|
-- |
|
-- |
|
$28.57M |
|
$-6.62M |
|
$-6.62M |
|
$-6.62M |
|
39.74M |
|
| Cash Flow Statement Financials | |
$-24.77M |
|
$34.05M |
|
$-8.48M |
|
$12.32M |
|
$13.13M |
|
$0.81M |
|
$4.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.76 |
|
-- |
|
-- |
|
-- |
|
-2.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.77M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
159.48% |
|
159.48% |
|
-48.06% |
|
159.48% |
|
$-0.17 |
|
$-0.63 |
|
|
Operating Cash Flow per Share |
$-0.63 |